Transgene annonce que l’option sur TG4010 n’est pas exercée
255_fr
By alcyon|2014-04-28T00:00:45+02:00avril 28th, 2014|Communiqué de presse, TG4010|Commentaires fermés sur Transgene annonce que l’option sur TG4010 n’est pas exercée
Combination of the oncolytic vaccinia virus TG6002 with conventional chemotherapeutic agents in human tumor models resistant to viral oncolysis.
Johann Foloppe, et al. 8th International Conference on Oncolytic Virus [...]